|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 22, 2017 ) Hematology drugs market offers drugs, blood and blood products that are used for the treatment of diseases such as rare genetic disorders, anemia, conditions related to sickle cell disease, and other related diseases.
The global hematology drugs market was estimated to be around $37 billion as of 2016. The hematology drugs market made up around 3.5% of the overall pharmaceuticals market in 2016. The hematology drugs market was the twelfth largest market in the global pharmaceutical market in 2016.
For more information about this report at http://www.reportsweb.com/hematology-drugs-market-global-report-2017
Product Approvals
Increase in number of hematology disease drug approvals from the regulatory bodies such as FDA in the US and EMA in EU is an emerging trend in the market. For instance, in June 2017, Novo Nordisk received FDA approval for its Rebinyn (Coagulation Factor IX (Recombinant), GlycoPEGylated) that is used in the treatment of hemophilia B. In April 2017, Novartis received FDA approval for its Rydapt (midostaurin) drug that is used in the treatment of positive acute myeloid leukemia and mastocytosis.
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001890204/sample
Table of Content
1. Hematology Drugs Market Characteristics
2. Hematology Drugs Market Size And Growth
3. Pestle Analysis
4. Hematology Drugs Market Customer Information
5. Hematology Drugs Market Segmentation
6. Hematology Drugs Market Regional And Country Analysis
7. Global Hematology Drugs Market Comparison With Macro Economic Factors
8. Hematology Drugs Market Comparison With Macro Economic Factors Across Countries
9. Hematology Drugs Market Comparison With Industry Metrics
10. Asia-Pacific Hematology Drugs Market
11. Western Europe Hematology Drugs Market
12. Eastern Europe Hematology Drugs Market
13. North America Hematology Drugs Market
14. South America Hematology Drugs Market
15. Middle East Hematology Drugs Market
16. Africa Hematology Drugs Market
17. Hematology Drugs Market Competitive Landscape
18. Key Mergers And Acquisitions In The Hematology Drugs Market
19. Market Background: Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
Companies Mentioned
Blood Products, Anemia And Other Blood Disorder Drugs
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001890204/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
